DiaMedica Therapeutics (DMAC) Inventory (2021 - 2023)

DiaMedica Therapeutics' Inventory history runs 3 years deep, the most recent figure standing at $317000.0 for Q4 2023.

• On a quarterly basis, Inventory rose 654.76% year-over-year to $317000.0 in Q4 2023; TTM through Dec 2023 was $317000.0, a 654.76% increase from a year earlier, with the FY2023 full-year figure at $317000.0, up 654.76% from the prior year.
• Inventory fell to $317000.0 in Q4 2023 per DMAC's latest filing, from $715000.0 in the prior quarter.
• Across five years, Inventory topped out at $715000.0 in Q3 2023 and bottomed at $42000.0 in Q4 2022.
• The 3-year median for Inventory is $102500.0 (2021), against an average of $223000.0.
• Across the five-year window, Inventory plunged 62.83% in 2022 and surged 654.76% in 2023, its largest moves.
• Year by year, Inventory stood at $113000.0 in 2021, then plunged by 62.83% to $42000.0 in 2022, then jumped by 654.76% to $317000.0 in 2023.
• Per Business Quant, the three latest DMAC Inventory figures stand at $317000.0 (Q4 2023), $715000.0 (Q3 2023), and $59000.0 (Q2 2023).